Advertisement

Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease (NTM PD) in the USA

  • Shelby Daniel-Wayman
  • Jennifer Adjemian
  • D. Rebecca Prevots
Chapter
Part of the Respiratory Medicine book series (RM)

Abstract

Population-based studies of pulmonary nontuberculous mycobacterial disease in the USA indicate increasing prevalence. Prevalence is higher among women, older populations, and persons of Asian ancestry. The most frequent species is Mycobacterium avium complex, although the proportion varies geographically, with high rates of Mycobacterium abscessus in areas including the Southeast. Both host and environmental factors modulate disease risk. Environmental risk factors include high vapor pressure and low soil pH, while host risk factors include structural lung disease, thoracic skeletal abnormalities, and immunomodulatory medications.

Keywords

Epidemiology Nontuberculous mycobacteria Pulmonary disease 

Notes

Acknowledgments

This research was supported by the Intramural Research Program of the NIAID, NIH.

References

  1. 1.
    Timpe A, Runyon EH. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954;44(2):202–9.PubMedGoogle Scholar
  2. 2.
    Parte AC. LPSN – list of prokaryotic names with standing in nomenclature. Nucleic Acids Res. 2014;42(Database issue):D613–6.  https://doi.org/10.1513/AnnalsATS.201610-802PS.CrossRefGoogle Scholar
  3. 3.
    Winthrop KL, Henkle E, Walker A, Cassidy M, Hedberg K, Schafer S. On the Reportability of nontuberculous mycobacterial disease to public health authorities. Ann Am Thorac Soc. 2016;14(3):314–7.  https://doi.org/10.1513/AnnalsATS.201610-802PS.CrossRefGoogle Scholar
  4. 4.
    Salfinger M, Falkinham JO, Leitman PB. Has the time come to require nontuberculous mycobacteria reporting? NTM-TB Insights. 2016:1–4.Google Scholar
  5. 5.
    Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970–6.CrossRefGoogle Scholar
  6. 6.
    Adjemian J, Frankland TB, Daida YG, Honda JR, Oliver KN, Zelazny A, Honda S, Prevots DR. Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA. Emerg Infect Dis. 2017;23(3):439–47.  https://doi.org/10.3201/eid2303.161827.CrossRefGoogle Scholar
  7. 7.
    Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, Pfaller SL, Maillard JM, Hilborn ED. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect. 2016;72(6):678–86.  https://doi.org/10.1016/j.jinf.2016.03.008.CrossRefGoogle Scholar
  8. 8.
    Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182:977–82.CrossRefGoogle Scholar
  9. 9.
    Henkle E, Hedberg K, Schafer SD, Winthrop KL. Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007-2012. Emerg Infect Dis. 2017;23(10):1627–30.  https://doi.org/10.3201/eid2310.170845.CrossRefGoogle Scholar
  10. 10.
    Donohue MJ, Wymer L. Increasing prevalence rate of nontuberculous mycobacteria infections in five states, 2008-2013. Ann Am Thorac Soc. 2016;13(12):2143–50.  https://doi.org/10.1513/AnnalsATS.201605-353OC.CrossRefGoogle Scholar
  11. 11.
    Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167(6):828–34.  https://doi.org/10.1164/rccm.200207-678OC.CrossRefGoogle Scholar
  12. 12.
    Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among cystic fibrosis patients in the United States: screening practices and environmental risk. Am J Respir Crit Care Med. 2014;190(5):581–6.  https://doi.org/10.1164/rccm.201405-0884OC.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881–6.CrossRefGoogle Scholar
  14. 14.
    Vinnard C, Longworth S, Mezochow A, Patrawalla A, Kreiswirth BN, Hamilton K. Deaths related to nontuberculous mycobacterial infections in the United States, 1999-2014. Ann Am Thorac Soc. 2016;13(11):1951–5.  https://doi.org/10.1513/AnnalsATS.201606-474BC.CrossRefGoogle Scholar
  15. 15.
    Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, Subcommittee ATSMD, American Thoracic Society, Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.  https://doi.org/10.1164/rccm.200604-571ST.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12(5):642–7.  https://doi.org/10.1513/AnnalsATS.201412-559OC.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Statistics Canada. Population and dwelling count highlight tables, 2016 census. Ottawa: Statistics Canada; 2017.Google Scholar
  18. 18.
    Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013;19(11):1889–91.CrossRefGoogle Scholar
  19. 19.
    Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf. 2011;20(3):229–35.  https://doi.org/10.1002/pds.2049.CrossRefPubMedGoogle Scholar
  20. 20.
    Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9–16.  https://doi.org/10.1513/AnnalsATS.201304-085OC.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Strollo SE, Adjemian J, Adjemian MK, Prevots DR. The burden of pulmonary nontuberculous mycobacterial disease in the United States. Ann Am Thorac Soc. 2015;12(10):1458–64.  https://doi.org/10.1513/AnnalsATS.201503-173OC.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Diel R, Ringshausen FC, Richter E, Welker L, Schmitz J, Nienhaus A. Microbiological and clinical outcomes of treating non-MAC NTM pulmonary disease: a systematic review and meta-analysis. Chest. 2017;152(1):120–42.  https://doi.org/10.1016/j.chest.2017.04.166.CrossRefPubMedGoogle Scholar
  23. 23.
    Novosad SA, Henkle E, Schafer S, Hedberg K, Ku J, Siegel SA, Choi D, Slatore CG, Winthrop KL. Mortality after respiratory isolation of nontuberculous mycobacteria: a comparison of patients who did and did not meet disease criteria. Ann Am Thorac Soc. 2017;14(7):1112–9.  https://doi.org/10.1513/AnnalsATS.201610-800OC.
  24. 24.
    Prevots DR, Adjemian J, Fernandez AG, Knowles MR, Olivier KN. Environmental risks for nontuberculous mycobacteria: individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc. 2014;11(7):1032–8.  https://doi.org/10.1513/AnnalsATS.201404-184OC.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Dirac MA, Horan KL, Doody DR, Meschke JS, Park DR, Jackson LA, Weiss NS, Winthrop KL, Cangelosi GA. Environment or host?: a casecontrol study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;186(7):684–91.  https://doi.org/10.1164/rccm.201205-0825OC.CrossRefGoogle Scholar
  26. 26.
    Maekawa K, Ito Y, Hirai T, Kubo T, Imai S, Tatsumi S, Fujita K, Takakura S, Niimi A, Iinuma Y, Ichiyama S, Togashi K, Mishima M. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest. 2011;140(3):723–9.  https://doi.org/10.1378/chest.10-2315.CrossRefGoogle Scholar
  27. 27.
    Adjemian J, Olivier KN, Seitz AE, Falkinham JO 3rd, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012;186(6):553–8.  https://doi.org/10.1164/rccm.201205-0913OC.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Lipner EM, Knox D, French J, Rudman J, Strong M, Crooks JL. A geospatial epidemiologic analysis of nontuberculous mycobacterial infection: an ecological study in Colorado. Ann Am Thorac Soc. 2017;14(10):1523–32.  https://doi.org/10.1513/AnnalsATS.201701-081OC.CrossRefGoogle Scholar
  29. 29.
    Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 2014;146(3):563–72.  https://doi.org/10.1378/chest.13-2058.CrossRefPubMedGoogle Scholar
  30. 30.
    Lande L, Peterson DD, Gogoi R, Daum G, Stampler K, Kwait R, Yankowski C, Hauler K, Danley J, Sawicki K, Sawicki J. Association between pulmonary Mycobacterium avium complex infection and lung cancer. J Thorac Oncol. 2012;7(9):1345–51.  https://doi.org/10.1097/JTO.0b013e31825abd49.CrossRefGoogle Scholar
  31. 31.
    Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169(4):459–67.  https://doi.org/10.1164/rccm.200303-365OC.CrossRefPubMedGoogle Scholar
  32. 32.
    Fowler CJ, Olivier KN, Leung JM, Smith CC, Huth AG, Root H, Kuhns DB, Logun C, Zelazny A, Frein CA, Daub J, Haney C, Shelhamer JH, Bryant CE, Holland SM. Abnormal nasal nitric oxide production, ciliary beat frequency, and toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med. 2013;187(12):1374–81.  https://doi.org/10.1164/rccm.201212-2197OC.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, McFarland B, Austin D, Radcliffe L, Suhler E, Choi D, Rosenbaum JT, Herrinton LJ. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2013;72(1):37–42.  https://doi.org/10.1136/annrheumdis-2011-200690.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin JP, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool L, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O'Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178:1066–74.CrossRefGoogle Scholar
  35. 35.
    Leung JM, Fowler C, Smith C, Adjemian J, Frein C, Claypool RJ, Holland SM, Prevots RD, Olivier K. A familial syndrome of pulmonary nontuberculous mycobacteria infections. Am J Respir Crit Care Med. 2013;188(11):1373–6.  https://doi.org/10.1164/rccm.201306-1059LE.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest. 2010;137(3):629–34.  https://doi.org/10.1378/chest.09-1173.CrossRefPubMedGoogle Scholar
  37. 37.
    Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM. Pulmonary nontuberculous mycobacterial infection. A multisystem, multigenic disease. Am J Respir Crit Care Med. 2015;192(5):618–28.  https://doi.org/10.1164/rccm.201502-0387OC.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. Clinical and laboratory studies of tuberculosis and respiratory disease: the navy recruit program. Am Rev Respir Dis. 1969;99(4(2)):1–132.Google Scholar
  39. 39.
    Kirschner RA Jr, Parker BC, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis. 1992;145(2 Pt 1):271–5.  https://doi.org/10.1164/ajrccm/145.2_Pt_1.271.CrossRefGoogle Scholar
  40. 40.
    Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, Adjemian J. Geographic distribution of nontuberculous mycobacterial species identified among clinical isolates in the United States, 2009-2013. Ann Am Thorac Soc. 2017;14(11):1655–61.  https://doi.org/10.1513/AnnalsATS.201611-860OC.CrossRefGoogle Scholar
  41. 41.
    Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17(3):419–24.  https://doi.org/10.3201/eid1703.101510.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Thomson R, Tolson C, Carter R, Coulter C, Huygens F, Hargreaves M. Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol. 2013;51(9):3006–11.  https://doi.org/10.1128/jcm.00899-13.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Schulze-Robbecke R, Buchholtz K. Heat susceptibility of aquatic mycobacteria. Appl Environ Microbiol. 1992;58(6):1869–73.PubMedPubMedCentralGoogle Scholar
  44. 44.
    De Groote MA, Pace NR, Fulton K, Falkinham JO 3rd. Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils. Appl Environ Microbiol. 2006;72(12):7602–6.  https://doi.org/10.1128/aem.00930-06.CrossRefGoogle Scholar
  45. 45.
    Fujita K, Ito Y, Hirai T, Maekawa K, Imai S, Tatsumi S, Niimi A, Iinuma Y, Ichiyama S, Mishima M. Genetic relatedness of Mycobacterium avium-intracellulare complex isolates from patients with pulmonary MAC disease and their residential soils. Clinical microbiology and infection: the official publication of the European society of. Clin Microbiol Infect Dis. 2013;19(6):537–41.  https://doi.org/10.1111/j.1469-0691.2012.03929.x.CrossRefGoogle Scholar
  46. 46.
    Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, Cangelosi GA, Olivier KN, Brown-Elliott BA, McNulty S, Wallace RJ Jr. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med. 2012;185:231–2.CrossRefGoogle Scholar
  47. 47.
    Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381(9877):1551–60.  https://doi.org/10.1016/s0140-6736(13)60632-7.CrossRefGoogle Scholar
  48. 48.
    Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jonsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science (New York, NY). 2016;354(6313):751–7.  https://doi.org/10.1126/science.aaf8156.CrossRefGoogle Scholar
  49. 49.
    Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VC, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis. 2014;20(3):364–71.  https://doi.org/10.3201/eid2003.131106.CrossRefGoogle Scholar
  50. 50.
    Malcolm KC, Caceres SM, Honda JR, Davidson RM, Epperson LE, Strong M, Chan ED, Nick JA. Mycobacterium abscessus displays fitness for fomite transmission. Appl Environ Microbiol. 2017.  https://doi.org/10.1128/aem.00562-17.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Shelby Daniel-Wayman
    • 1
  • Jennifer Adjemian
    • 1
    • 2
  • D. Rebecca Prevots
    • 1
  1. 1.Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, Division of Intramural ResearchNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesdaUSA
  2. 2.United States Public Health Service, Commissioned CorpsRockvilleUSA

Personalised recommendations